References in periodicals archive ?
FIS and heterozygosity calculated for each population from twelve microsatellite loci in Chinese pond turtle.
[F.sub.IS] displays value between -1 and +1, where positive values indicate heterozygote deficiency (inbreeding) and negative values depicts heterozygosity excess (out breeding) (40).
Observed heterozygosity ranged from 0.000 to 0.531 and expected heterozygosity from 0.031 to 0.751, with an average of 0.200 and 0.422, respectively.
The observed heterozygosity value ranged from 0.417 [+ or -] 0.321 (Banteng) to 0.719 [+ or -] 0.158 (Simmental Crossbred) and the expected heterozygosity value ranged from 0.550 [+ or -] 0.248 (Banteng) to 0.796 [+ or -] 0.151 (Madura).
When the population is in HWE, the distribution frequency of alleles in the population should be relatively stable, and there is no significant difference between observed heterozygosity and expected heterozygosity.
The observed heterozygosity percentage (Ho) of 15 STR loci ranged from 11.3 for FGA to 36.7 for TPOX, while it was expected that heterozygosity percentage (He) would vary between 63.3 for TPOX and 88.7 for FGA.
Observed heterozygosity and expected heterozygosity, number of alleles, effective number of alleles, deviations from Hardy Weinberg equilibrium and all other statistics were computed in Genalex 6.502 [20].
The genetic diversity of adult and sub-adult individuals was estimated based on the total number of alleles (k), on the highest allelic frequency (Fa), on the observed ([H.sub.o]) and expected (He) heterozygosity (at Hardy-Weinberg equilibrium in each locus and across all loci), and on the polymorphism information content (PIC), in order to verify the quality of the used loci.
Using POPGENE intrabreed genetic variation was estimated on the basis of observed heterozygosity (Ho) and mean unbiased estimates of gene diversity (He) (Nei 1978).
Genetic testing of both revealed NPR2 heterozygosity. We also report the patient's response to recombinant human growth hormone (rhGH).
Here, we report the development of iron overload in a nonhemochromatotic patient following liver transplantation from a donor with compound C282Y/H63D heterozygosity.
The remainder of 22 distinct mutations was detected once in heterozygosity each accounting for 0.8% (n =118) (Supplementary Table 2, Table 1), including five of the six previously unreported potentially pathogenic mutations p.Trp12* (exon 1), p.Asn76Thr (exon 3), p.Ser673Argfs*6 (exon 14), p.Cys698Arg (exon 14), and c.4352+4A>C (intron 29).
The observed heterozygosity, expected heterozygosity and polymorphism information content of BP were 0.463, 0.646 and 0.281, respectively, while those of HP were 0.309, 0.320 and 0.259, respectively.
Heterozygosity rate was determined for each polymorphism.
The molecular genetic analysis of PTEN gene sequencing revealed de novo p.N292Kfs*6 (c.872_873insA) heterozygosity. The mutation has already been reported in Cowden Syndrome (CS) that is another PTEN Hamartomatous Tumor Syndrome, but to our knowledge, this variant has not been reported previously for association with BRRS.